HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nam Keun Kim Selected Research

5,10-methylenetetrahydrofolic acid

9/2010Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin.
9/2007Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia.
11/2006Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population.
10/2005MTHFR C677T polymorphism associates with unexplained infertile male factors.
5/2005Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nam Keun Kim Research Topics

Disease

32Neoplasms (Cancer)
01/2022 - 03/2002
18Primary Ovarian Insufficiency
02/2021 - 06/2008
17Ischemic Stroke
03/2021 - 04/2007
15Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2011
12Stroke (Strokes)
11/2020 - 09/2011
11Spontaneous Abortion (Miscarriage)
09/2014 - 01/2006
7Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 04/2011
6Brain Infarction
03/2021 - 01/2010
6Stomach Neoplasms (Stomach Cancer)
11/2013 - 05/2005
5Inflammation (Inflammations)
01/2019 - 11/2012
5Carcinogenesis
09/2018 - 03/2002
5Colonic Neoplasms (Colon Cancer)
11/2014 - 07/2005
4Coronary Artery Disease (Coronary Atherosclerosis)
11/2020 - 01/2007
4Venous Thromboembolism
08/2019 - 07/2012
4Thrombosis (Thrombus)
08/2019 - 10/2013
4Hepatocellular Carcinoma (Hepatoma)
01/2016 - 09/2008
4Moyamoya Disease (Moya-Moya Disease)
10/2014 - 01/2012
3Cerebrovascular Disorders (Cerebrovascular Occlusion)
03/2020 - 05/2005
3Rectal Neoplasms (Rectal Cancer)
05/2019 - 12/2013
3Hypertension (High Blood Pressure)
01/2019 - 06/2014
3Atherosclerosis
01/2019 - 09/2011
3Diabetes Mellitus
01/2019 - 05/2010
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2007 - 05/2005
3Male Infertility (Male Sterility)
12/2006 - 03/2002
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2019
2Hyperlipidemias (Hyperlipidemia)
01/2020 - 01/2019
2Compression Fractures (Compression Fracture)
01/2020 - 12/2016
2Neoplasm Metastasis (Metastasis)
01/2020 - 06/2015
2Ischemia
07/2016 - 07/2012
2Chronic Hepatitis B
07/2015 - 09/2005
2Breast Neoplasms (Breast Cancer)
04/2015 - 02/2005
2Hyperhomocysteinemia
10/2014 - 01/2006
2Cardiovascular Diseases (Cardiovascular Disease)
02/2013 - 09/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2010 - 05/2007
2Basal Cell Carcinoma (Rodent Ulcer)
09/2010 - 05/2007
2Infertility (Sterility)
03/2003 - 03/2002
1Hypoxia (Hypoxemia)
10/2020
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
10/2020
1Blood Coagulation Disorders
01/2020
1Osteoporosis
01/2020
1Macular Degeneration (Age-Related Maculopathy)
12/2019
1Thrombotic Thrombocytopenic Purpura
09/2019
1Thrombotic Microangiopathies
09/2019
1Atypical Hemolytic Uremic Syndrome
09/2019

Drug/Important Bio-Agent (IBA)

27MicroRNAs (MicroRNA)IBA
11/2020 - 11/2011
17Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2017 - 07/2005
15Folic Acid (Vitamin M)FDA LinkGeneric
01/2020 - 05/2005
12HomocysteineIBA
01/2020 - 01/2006
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 07/2007
11DNA (Deoxyribonucleic Acid)IBA
02/2013 - 03/2002
9Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2022 - 01/2007
9Thymidylate SynthaseIBA
03/2021 - 07/2005
7Proteins (Proteins, Gene)FDA Link
10/2020 - 03/2002
6Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2014
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 01/2007
55,10-methylenetetrahydrofolic acidIBA
09/2010 - 05/2005
5Oxidoreductases (Dehydrogenase)IBA
09/2010 - 05/2005
4Plasminogen Activators (Plasminogen Activator)IBA
11/2020 - 03/2014
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2015 - 01/2010
4Phosphotransferases (Kinase)IBA
11/2013 - 01/2012
3Plasminogen Activator Inhibitor 1IBA
11/2020 - 10/2013
3Mannitol (Osmitrol)FDA LinkGeneric
10/2020 - 01/2018
3Reduced Folate Carrier ProteinIBA
01/2020 - 05/2012
3EnzymesIBA
09/2007 - 03/2002
3Messenger RNA (mRNA)IBA
11/2003 - 03/2002
2Antisense RNA (Anti-Sense RNA)IBA
03/2021 - 02/2021
2Long Noncoding RNAIBA
03/2021 - 01/2020
2Genetic Markers (Genetic Marker)IBA
10/2020 - 12/2013
2Transcobalamins (Transcobalamin II)IBA
01/2020 - 09/2014
2Complement System Proteins (Complement)IBA
12/2019 - 09/2019
2Matrix Metalloproteinases (MMPs)IBA
02/2019 - 10/2014
2Tissue Inhibitor of MetalloproteinasesIBA
02/2019 - 10/2014
2Pharmaceutical PreparationsIBA
01/2018 - 07/2015
2Codon (Codons)IBA
02/2014 - 02/2005
2Fluorouracil (Carac)FDA LinkGeneric
01/2014 - 07/2005
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
05/2013 - 10/2011
2AngiotensinogenIBA
05/2013 - 10/2011
2Type 1 Angiotensin ReceptorIBA
05/2013 - 10/2011
2Annexin A1IBA
11/2012 - 07/2012
2Lamivudine (Epivir)FDA Link
09/2005 - 05/2004
2Monoclonal AntibodiesIBA
11/2003 - 03/2002
2DNA-3-methyladenine glycosidase IIIBA
03/2003 - 03/2002
1Neprilysin (Neutral Endopeptidase)IBA
01/2021
1Therapeutic UsesIBA
01/2021
1Lipoproteins (Lipoprotein)IBA
11/2020
1LigandsIBA
10/2020
1ChemokinesIBA
10/2020
1Biological ProductsIBA
03/2020
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2020
1Vitamin B Complex (B Vitamins)IBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1Immunologic Factors (Immunomodulators)IBA
01/2020
1Thiamine (Aneurin)FDA Link
01/2020
1Vitamin DFDA LinkGeneric
01/2020
1Complement Factor D (Factor D)IBA
12/2019
1Complement Factor H (Factor H)IBA
12/2019
1thiamine triphosphorate (TTP)IBA
09/2019

Therapy/Procedure

4Drug Therapy (Chemotherapy)
04/2016 - 07/2005
2Therapeutics
01/2019 - 05/2004
1Intravenous Administration
10/2020